BSECompany Update11h ago · 18 Nov 2026, 09:18 pm
Newspaper publication for Financial Results for quarter and half year ended 30.09.2026
Parmax Pharma Ltd · 540359
✦ AI SummaryResults
Parmax Pharma Ltd has published its financial results for the quarter and half year ended September 30, 2026, in The Financial Express newspaper.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Parmax Pharma Ltd - 540359 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Attachments (1)
📄pdf
Download →
5188000b-598c-4e20-98c4-e0585a5512f1.pdf
View document text
November 18, 2026
The Department of Corporate Services,
BSE Limited,
Mumbai
BSE Script Code: 540359
Dear Sir /Madam,
SUB : NEWSPAPER CUTTING U/R 30 OF THE SEBI (LODR) REGULATIONS, 2015
REF : PUBLICATION OF FINANCIAL RESULTS U/R 33 OF THE SEBI (LODR)
REGULATIONS, 2015
With respect to above subject, this is to inform the stock exchanges that
pursuant to Regulation 30, 33 and 47 read with Part A(12) of Schedule III of the
SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015 and in
continuation to our letter dated November 17, 2026 with regard to outcome of
board meeting held on that day, please find enclosed a copy of relevant page of
the newspaper
The Financial Express in English and Financial Express in Gujarati Edition in which
the extract of Financial Results for the quarter and half year ended on
September 30, 2026 were published for the information of members.
Yours faithfully,
For Parmax Pharma Limited
Umang Gosalia
Managing Director
DIN: 05153830